Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Human Papillomavirus Vaccine Impact and Effectiveness Through 12 Years After Vaccine Introduction in the United States, 2003 to 2018
Hannah G. Rosenblum, Rayleen M. Lewis, Julia W. Gargano, et al.
Annals of Internal Medicine (2022) Vol. 175, Iss. 7, pp. 918-926
Closed Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

Cancer statistics, 2023
Rebecca L. Siegel, Kimberly D. Miller, Nikita Sandeep Wagle, et al.
CA A Cancer Journal for Clinicians (2023) Vol. 73, Iss. 1, pp. 17-48
Open Access | Times Cited: 11514
Human papillomavirus vaccination and cervical cancer risk
Lisa Rahangdale, Chemtai Mungo, Siobhán O’Connor, et al.
BMJ (2022), pp. e070115-e070115
Open Access | Times Cited: 93
Cancer statistics, 2025
Rebecca L. Siegel, Tyler B. Kratzer, Angela N. Giaquinto, et al.
CA A Cancer Journal for Clinicians (2025)
Open Access | Times Cited: 52
Advances in HPV‐associated tumor management: Therapeutic strategies and emerging insights
Xiangjin Gong, Hao Chi, Zhijia Xia, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 7
Closed Access | Times Cited: 38
A systematic review of interventions to promote HPV vaccination globally
Cam Escoffery, Courtney N. Petagna, Christine Agnone, et al.
BMC Public Health (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 29
Navigating therapeutic strategies: HPV classification in head and neck cancer
Hossein Tabatabaeian, Yuchen Bai, Ruihong Huang, et al.
British Journal of Cancer (2024) Vol. 131, Iss. 2, pp. 220-230
Open Access | Times Cited: 13
Prevalence and genotype distribution of HPV infections among women in Chengdu,China
Junying Zhang, Tianzhi Zha, Xuemei Wang, et al.
Virology Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 7
Cervical Cancer Screening
Katherine Gavinski, Deborah DiNardo
Medical Clinics of North America (2022) Vol. 107, Iss. 2, pp. 259-269
Closed Access | Times Cited: 23
Health and economic impact of delaying large-scale HPV vaccination and screening implementation on cervical cancer in China: a modelling study
Meng Gao, Shangying Hu, Xuelian Zhao, et al.
The Lancet Regional Health - Western Pacific (2023) Vol. 36, pp. 100768-100768
Open Access | Times Cited: 15
Cancer theragnostics: closing the loop for advanced personalized cancer treatment through the platform integration of therapeutics and diagnostics
Olga V. Sergeeva, Liang Luo, Anthony Guiseppi‐Elie
Frontiers in Bioengineering and Biotechnology (2025) Vol. 12
Open Access
Validating the predicted impact of HPV vaccination on HPV prevalence, cervical lesions, and cervical cancer: A systematic review of population level data and modelling studies
Daniel D de Bondt, Emi Naslazi, Erik E.L. Jansen, et al.
Gynecologic Oncology (2025) Vol. 195, pp. 134-143
Open Access
Colposcopy Standards: Guidelines for Endocervical Curettage at Colposcopy
L. Stewart Massad, Rebecca B. Perkins, Amber Naresh, et al.
Journal of Lower Genital Tract Disease (2022)
Open Access | Times Cited: 21
Extended human papillomavirus genotype distribution in cervical intraepithelial neoplasia and cancer: Analysis of 40 352 cases from a large academic gynecologic center in China
Xiao Tang, Terrell E. Jones, Wei Jiang, et al.
Journal of Medical Virology (2022) Vol. 95, Iss. 1
Closed Access | Times Cited: 21
Updated estimate of the annual direct medical cost of screening and treatment for human papillomavirus associated disease in the United States
P. A. Clay, Trevor Thompson, Lauri E. Markowitz, et al.
Vaccine (2023) Vol. 41, Iss. 14, pp. 2376-2381
Closed Access | Times Cited: 11
High impact of quadrivalent human papillomavirus vaccine across racial/ethnic groups: National Health and Nutrition Examination Survey, 2003–2006 and 2015–2018
Ruth Stefanos, Rayleen M. Lewis, Troy D. Querec, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 3
U.S. Women with Invasive Cervical Cancer: Characteristics and Potential Barriers to Prevention
Hannah G. Rosenblum, Julia W. Gargano, Angela A. Cleveland, et al.
Journal of Women s Health (2024) Vol. 33, Iss. 5, pp. 594-603
Closed Access | Times Cited: 3
Facilitators and barriers of HPV vaccination: a qualitative study in rural Georgia
Courtney N. Petagna, Stephen Perez, Erica Hsu, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Predictable changes in the accuracy of human papillomavirus tests after vaccination: review with implications for performance monitoring in cervical screening
Matejka Rebolj, Adam R. Brentnall, Kate Cuschieri
British Journal of Cancer (2024) Vol. 130, Iss. 11, pp. 1733-1743
Open Access | Times Cited: 2
Recommending HPV vaccination at age 9 to reduce health disparities: Communication challenges and opportunities
Tamera Coyne‐Beasley, Rebecca Ortiz
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 1
Open Access | Times Cited: 6
Prevalence and genotype distribution of HPV6/11/16/18 infections among 180,276 outpatient females from a Women’s and Children’s Central Hospital, 2015–2021, Chengdu, China
Xiaoqing Wei, Junying Zhang, Youwen Mei, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 6
Prevalence of High-Risk HPV Detection and HPV Vaccination in Cervical Cancer Screening During the HPV Vaccination Era at Siriraj Hospital – Thailand’s Largest National Tertiary Referral Center
Pattama Chaopotong, Somsak Laiwejpithya, Chatchai Areeswate
Asian Pacific Journal of Cancer Prevention (2024) Vol. 25, Iss. 4, pp. 1241-1245
Open Access | Times Cited: 1
Potential impact of switching from a two- to one-dose gender-neutral routine HPV vaccination program in Canada: A mathematical modeling analysis
Mélanie Drolet, Jean‐François Laprise, Éléonore Chamberland, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Human papillomavirus vaccination and Pap test uptake, awareness, and barriers among young adults in Gulf Cooperation Council countries: a comparative cross-sectional survey
Ibrahim Mahmoud, Mithaq Mohammed A Al Eid, Meera Ahmed Mohamed, et al.
Journal of Infection and Public Health (2024) Vol. 17, Iss. 10, pp. 102525-102525
Open Access | Times Cited: 1
Epidemiology of human papillomavirus-associated anogenital cancers in Granada: a three-decade population-based study
Pablo Dabán López, Nicolás Francisco Fernández‐Martínez, Dafina Petrova, et al.
Frontiers in Public Health (2023) Vol. 11
Open Access | Times Cited: 4
Parental perceptions of the HPV vaccine for prevention of anogenital and oropharyngeal cancers
Beth I. Schwartz, Merissa Maccani, Shalini Bansal, et al.
Vaccine X (2023) Vol. 14, pp. 100298-100298
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top